| Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia RH Böger, SM Bode-Böger, A Szuba, PS Tsao, JR Chan, O Tangphao, ... Circulation 98 (18), 1842-1847, 1998 | 1719 | 1998 |
| Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study C Zoccali, SM Bode-Böger, F Mallamaci, FA Benedetto, G Tripepi, ... The Lancet 358 (9299), 2113-2117, 2001 | 1359 | 2001 |
| LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial Cells: Involvement of S-Adenosylmethionine–Dependent … RH Böger, K Sydow, J Borlak, T Thum, H Lenzen, B Schubert, D Tsikas, ... Circulation research 87 (2), 99-105, 2000 | 749 | 2000 |
| Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease RH Böger, SM Bode-Böger, W Thiele, W Junker, K Alexander, ... Circulation 95 (8), 2068-2074, 1997 | 719 | 1997 |
| Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetric dimethylarginine in humans JT Kielstein, B Impraim, S Simmel, SM Bode-Boger, MM Hoeper, H Haller, ... JOURNAL OF HYPERTENSION 22, S29-S29, 2004 | 528 | 2004 |
| Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans JT Kielstein, B Impraim, S Simmel, SM Bode-Böger, D Tsikas, ... Circulation 109 (2), 172-177, 2004 | 528 | 2004 |
| Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease JT Kielstein, RH Böger, SM Bode-Böger, JC Frölich, H Haller, E Ritz, ... Journal of the American Society of Nephrology 13 (1), 170-176, 2002 | 495 | 2002 |
| The clinical pharmacology of L-arginine RH Böger, SM Bode-Böger Annual review of pharmacology and toxicology 41 (1), 79-99, 2001 | 491 | 2001 |
| Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis JT Kielstein, SR Salpeter, SM Bode-Boeger, JP Cooke, D Fliser Nephrology Dialysis Transplantation 21 (9), 2446-2451, 2006 | 450 | 2006 |
| Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study D Fliser, F Kronenberg, JT Kielstein, C Morath, SM Bode-Böger, H Haller, ... Journal of the American Society of Nephrology 16 (8), 2456-2461, 2005 | 449 | 2005 |
| The L-arginine paradox: importance of the L-arginine/asymmetrical dimethylarginine ratio SM Bode-Böger, F Scalera, LJ Ignarro Pharmacology & therapeutics 114 (3), 295-306, 2007 | 435 | 2007 |
| Elevatedl-Arginine/Dimethylarginine ratio contributes to enhanced systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits SM Bode-Böger, RH Böger, S Kienke, W Junker, JC Frölich Biochemical and biophysical research communications 219 (2), 598-603, 1996 | 419 | 1996 |
| Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst (e) inemia or hypercholesterolemia RH Böger, SM Bode-Böger, K Sydow, DD Heistad, SR Lentz Arteriosclerosis, thrombosis, and vascular biology 20 (6), 1557-1564, 2000 | 409 | 2000 |
| Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease SM Bode-Böger, F Scalera, JT Kielstein, J Martens-Lobenhoffer, ... Journal of the American Society of Nephrology 17 (4), 1128-1134, 2006 | 388 | 2006 |
| L‐arginine‐induced vasodilation in healthy humans: pharmacokinetic–pharmacodynamic relationship SM Bode‐Böger, RH Böger, A Galland, D Tsikas, JC Frölich British journal of clinical pharmacology 46 (5), 489-497, 1998 | 376 | 1998 |
| Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease RH Böger, SM Bode-Böger, W Thiele, A Creutzig, K Alexander, JC Frölich Journal of the American College of Cardiology 32 (5), 1336-1344, 1998 | 370 | 1998 |
| Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. GI Köhler, SM Bode-Böger, R Busse, M Hoopmann, T Welte, RH Böger International journal of clinical pharmacology and therapeutics 38 (11), 504-513, 2000 | 368 | 2000 |
| An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes RH Böger, SM Bode-Böger, PS Tsao, PS Lin, JR Chan, JP Cooke Journal of the American College of Cardiology 36 (7), 2287-2295, 2000 | 364 | 2000 |
| Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. RH Böger, C Skamira, SM Bode-Böger, G Brabant, A Von Zur Muhlen, ... The Journal of clinical investigation 98 (12), 2706-2713, 1996 | 361 | 1996 |
| Dietary l-Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits: Comparison With Lovastatin RH Boger, SM Bode-Böger, RP Brandes, L Phivthong-ngam, ... Circulation 96 (4), 1282-1290, 1997 | 357 | 1997 |
